コンテンツへスキップ
Merck

SBR00027

Sigma-Aldrich

Lipopolysaccharides from Akkermansia muciniphila

Purified by phenol extraction

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352201
NACRES:
NA.25

由来生物

(Akkermansia muciniphila)

品質水準

形状

lyophilized powder

white to faint yellow

溶解性

water: 1 mg/mL, faintly hazy to hazy, colorless to light yellow

保管温度

2-8°C

詳細

Akkermansia muciniphila (A. muciniphila) is a Gram-negative, anaerobic, non-motile, non-spore-forming, and oval-shaped bacterium. A. muciniphila inhabits the gastrointestinal tracts of more than 90% of adults and constitutes 1-4% of the fecal microbiota. A. muciniphila levels were suggested to serve as a biomarker for a healthy intestine.
Lipopolysaccharides (LPS) are complex molecules composed of lipids and polysaccharides that are predominantly found in the outer membrane of Gram-negative bacteria. They consist of three main components: lipid A, the core oligosaccharide (core), and the O-specific polysaccharide or O antigen (OAg). Lipid A is firmly linked to the outer bacterial membrane and is primarily responsible for the toxicity associated with LPS. LPS serves as a potent activator of the proinflammatory response in various types of mammalian cells, including macrophages, monocytes, and endothelial cells. Beyond its protective role for Gram-negative bacteria against environmental stress, LPS is also recognized by the innate immune system during infection.

アプリケーション

Lipopolysaccharides may have been used as a cell culture treatment:
  • to impair barrier functions of Caco-2 cell monolayers tight junction
  • cocultured along with A. muciniphila to study its effects on the NLR family pyrin domain containing 3 (NLRP3) expressions in Raw264.7 cells
  • to activate HepG2 cells as an endotoxin together with palmitic acid (PA)

生物化学的/生理学的作用

LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular patterns (PAMPs).,
A. muciniphila degrades mucus and utilizes it as a carbon/nitrogen source. Consequently, the host produces additional mucus while the bacterium produces oligosaccharides and Short Chain Fatty Acids (SCFAs) that can be utilized by the host and trigger the immune system. An additional protective effect of the SCFA is stimulation of mucus-associated microbiota growth, that serves as a barrier against penetration of pathogens to intestinal cells.,
A. muciniphila was crowned as the next-generation beneficial microbe. Several reports have indicated that A. muciniphila affects glucose metabolism, lipid metabolism, and intestinal immunity. In addition, decreasing levels of A. muciniphila are related to the development of some diseases such as metabolic disorders and inflammatory diseases (obesity, type 2 diabetes, inflammatory bowel disease (IBD), autism and atopy. Weir et al. found a correlation between low level of A. muciniphila and colorectal cancer. Shigemetzu Y et al. found that A. muciniphila acts as a regulator of the response to PD-1 blockade which is used for anti-cancer immunotherapy. A. muciniphila induce dendritic cells to secrete IL-12, that is a critical component of the anti-cancer effect of PD-1 blockade.
LPSs from A. muciniphila stimulate NF-κB dependent secreted embryonic cell alkaline phosphatase (SEAP) production via TLR4. In addition, it induces IL-8, IL-6 and minimal amounts of IL-10 and TNF-α in peripheral blood mononuclear cells (PBMCs). A. muciniphila stimulation of IL-8 production by enterocytes was shown to be significantly (100 fold) lower than E. coli stimulation. Low proinflammatory activity keep the mucosa-associated immune system alerted at an appropriate level for generation of mucosal homeostasis.

その他情報

For additional information on our range of Biochemicals, please complete this form.
To gain a comprehensive understanding of our extensive range of Lipopolysaccharides for your research, we encourage you to visit our Carbohydrates Category page.

ピクトグラム

Skull and crossbones

シグナルワード

Danger

危険有害性情報

注意書き

危険有害性の分類

Acute Tox. 2 Oral

保管分類コード

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

SBR00027-BULK:
SBR00027-5MG:
SBR00027-5MG-PW:
SBR00027-VAR:


Choose from one of the most recent versions:

試験成績書(COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact カスタマーサポート

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Mucolytic bacteria with increased prevalence in IBD mucosaaugment in vitro utilization of mucin by other bacteria.
Png CW, Linden SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin TH.
The American Journal of Gastroenterology, 105(11), 2420-2428 (2010)
Microbes inside?from diversity to function: the case of Akkermansia.
Blezer C and DE Vos WM.
The ISME Journal, 6(8), 1449-1458 (2012)
LPS/TLR4 signal transduction pathway.
Lu YC, Yeh WC, Ohashi PS.
Cytokine, 42(2), 145-151 (2008)
Siwen Qu et al.
Microbiology spectrum, 9(2), e0073021-e0073021 (2021-10-07)
Akkermansia muciniphila has been proved to play a crucial role in the progression of colitis, but its underlying mechanism remains inconclusive. In this study, we aim to investigate the effect of A. muciniphila on the development of acute colitis and
Analysis of Lipopolysaccharides of Gram-Negative Bacteria.
Mayer H, Tharanathan RN, Weckesser J.
Methods in Microbiology, 18, 157-207 (1985)

資料

Explore the structure, function, and diverse applications of Lipopolysaccharides. Discover their role in bacteria, serological specificity, and research potential.

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)